✨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 105
23 JULY 2009
Product:
DBL® Oxaliplatin for injection
Active Ingredient:
Oxaliplatin 100mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Hospira NZ Limited
Manufacturer:
Hospira Australia Pty Limited, Mulgrave, Victoria, Australia
Product:
Dimetapp Daytime/Nightime Liquid Caps
Daytime
Active Ingredients:
Dextromethorphan hydrobromide monohydrate 10mg
Paracetamol 300mg
Dosage Form:
Capsule
Nightime
Active Ingredients:
Dextromethorphan hydrobromide monohydrate 10mg
Doxylamine succinate 6.25mg
Paracetamol 300mg
Dosage Form:
Capsule
New Zealand Sponsor:
Wyeth Consumer Healthcare a Division of Wyeth (NZ) Limited
Manufacturer:
Catalent Australia Pty Limited, Braeside, Victoria, Australia
Product:
Dimetapp Nightime Cold & Flu Liquid Caps
Active Ingredients:
Dextromethorphan hydrobromide monohydrate 10mg
Doxylamine succinate 6.25mg
Paracetamol 300mg
Dosage Form:
Liquid filled capsule
New Zealand Sponsor:
Wyeth Consumer Healthcare a Division of Wyeth (NZ) Limited
Manufacturer:
Catalent Australia Pty Limited, Braeside, Victoria, Australia
Product:
Irinotecan
Active Ingredient:
Irinotecan hydrochloride trihydrate 20mg/mL equivalent to irinotecan 17.33mg
Dosage Form:
Concentrate for infusion
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
GP-Pharm, S.A., Polígono Industrial Els Vinyets-Els Fogars, Barcelona, Spain
Product:
Lopresor
Active Ingredient:
Metoprolol tartrate 5mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Novartis Stein AG, Stein, Switzerland
Product:
Vigamox
Active Ingredient:
Moxifloxacin hydrochloride 0.545%w/v equivalent to moxifloxacin 0.5%w/v
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
Alcon New Zealand Limited
Manufacturer:
Alcon Laboratories Inc, Fort Worth, Texas, United States of America
Dated this 20th day of July 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).
go6204
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
Product:
Head & Shoulders Anti-Dandruff Shampoo for Men Hair Retain
Active Ingredient:
Pyrithione zinc 1%w/w
Dosage Form:
Shampoo
New Zealand Sponsor:
Procter & Gamble Distributing New Zealand
Manufacturer:
Procter & Gamble Manufacturing (Thailand) Limited, Bangsmark, Bangkpakong, Chacheonsao, Thailand
Dated this 20th day of July 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).
go6205
Next Page →
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare20 July 2009
Medicines, Consent, Distribution, Medicines Act 1981, Hospira NZ Limited, Wyeth Consumer Healthcare, Mylan New Zealand Limited, Novartis New Zealand Limited, Alcon New Zealand Limited, Oxaliplatin, Dimetapp, Irinotecan, Lopresor, Vigamox
- MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
🏥 Consent to the Distribution of a New Related Product
🏥 Health & Social Welfare20 July 2009
Medicines, Consent, Distribution, Medicines Act 1981, Procter & Gamble Distributing New Zealand, Head & Shoulders Anti-Dandruff Shampoo for Men Hair Retain
- MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
NZ Gazette 2009, No 105